Evidence map›Paper›PMID 42189504›Full record

ArticlePharmacoEconomics2026

Identifying and Comparing Intervention Cost Components in Remote Patient Monitoring: A Scoping Review.

Anna L Heilig, Wilbert B van den Hout, M Elske van den Akker-van Marle

Abstract readScoping ReviewComparative Study
In one paragraph

Article in PharmacoEconomics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Anna L HeiligDepartment of Biomedical Data Science, Leiden University Medical Center, Albinusdreef 2, Leiden, 2333 ZB, The Netherlands. A.L.Heilig@lumc.nl.ORCID http://orcid.org/0009-0007-5867-6547
Wilbert B van den HoutDepartment of Biomedical Data Science, Leiden University Medical Center, Albinusdreef 2, Leiden, 2333 ZB, The Netherlands.ORCID http://orcid.org/0000-0001-8480-4134
M Elske van den Akker-van MarleDepartment of Biomedical Data Science, Leiden University Medical Center, Albinusdreef 2, Leiden, 2333 ZB, The Netherlands.ORCID http://orcid.org/0000-0002-5269-509X

Funding

ZonMw, the Netherlands 10580012310007
6 · The paper itself

Abstract

BACKGROUND AND

objectiveRemote patient monitoring has shown promising outcomes, such as improved disease awareness and reduced hospital stay. However, assessing the cost of the remote patient monitoring itself is challenging owing to the lack of standardization and transparency in economic evaluations of remote patient monitoring. This review aims to identify and compare the cost components used to estimate the remote patient monitoring intervention costs and the reported challenges in assessing them.

methodsWe performed a scoping review of studies published in PubMed, Embase, and Web of Science that conducted an economic evaluation of a remote patient monitoring between January 2019 and March 2026. Titles and abstracts were screened. Relevant articles were subjected to full-text screening to assess eligibility, and reported cost components were counted based on predefined categories. Difficulties reported by the economic evaluation authors (challenges) were extracted and analyzed using thematic synthesis.

resultsA total of 1282 articles were identified, of which 84 studies met the eligibility criteria. Forty-nine (58%) studies had an observational design, and the remaining studies had a model design. Components of remote patient monitoring intervention costs were reported in 71 (85%) of the included studies, with staff salaries (62%) and equipment/technology (56%) costs being the most frequently reported. The most commonly reported challenge was uncertainty about which remote patient monitoring cost categories to include.

conclusionsThis review highlights the disparities in the assessment and reporting of remote patient monitoring intervention costs in economic evaluations. We offer an updated checklist and guidance for assessing and reporting intervention costs in future economic evaluations.

Indexed as

Remote Patient MonitoringCost-Benefit AnalysisHumans

Identifiers

PMID42189504
PMCPMC13499870

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.